Lyssikatos Joseph P

CIK 00019671501 companyBOULDER, CO

SEC Profile

Transactions

Companies

Filings

CIK

0001967150

Recent Transactions

50 trades

Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-01-20$26.90/sh−14,509→ 745,188 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-01-20$26.37/sh−5,491→ 759,697 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-01-09$24.90/sh−41,198→ 815,188 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-01-09$29.13/sh−50,000→ 765,188 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-01-08$20.13/sh−7,500→ 890,188 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-01-08$24.92/sh−33,802→ 856,386 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-11-19$22.30/sh−12,008→ 903,180 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-11-19$23.09/sh−492→ 902,688 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-10-20$22.08/sh−12,500→ 915,188 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-09-26$20.25/sh−4,000→ 927,688 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-09-23$20.03/sh−1,500→ 931,688 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-09-19$19.11/sh−4,870→ 935,318 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-09-19$20.02/sh−2,130→ 933,188 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-08-21$20.01/sh−7,500→ 940,188 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-08-19$19.62/sh−5,000→ 947,688 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-07-21$22.26/sh−11,924→ 953,264 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-07-21$22.90/sh−576→ 952,688 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-06-20$21.40/sh−12,500→ 965,188 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-06-03$20.03/sh−7,500→ 977,688 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-05-19$16.31/sh−5,000→ 985,188 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-05-02$20.01/sh−2,470→ 990,188 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-05-01$20.07/sh−5,030→ 992,658 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-04-21$16.72/sh−330→ 997,688 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-04-21$16.03/sh−4,670→ 998,018 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-03-19$20.61/sh−12,500→ 1,002,688 total
Award
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2025-02-06+171,000→ 171,000 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-10-18$30.00/sh−847→ 1,015,188 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-10-09$28.52/sh−3,589→ 1,016,035 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-10-09$28.12/sh−34,289→ 1,019,624 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-10-08$27.96/sh−13,167→ 1,054,013 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-10-08$28.51/sh−100→ 1,053,913 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-10-07$27.61/sh−2,707→ 1,067,180 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-10-04$27.51/sh−7,522→ 1,069,887 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-10-01$27.54/sh−527→ 1,077,409 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-08-29$23.08/sh−50→ 1,077,936 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-08-29$22.48/sh−11,950→ 1,077,986 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-07-31$27.56/sh−3,099→ 1,089,936 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-07-29$27.43/sh−203→ 1,093,035 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-07-29$26.69/sh−11,797→ 1,093,238 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-07-01$22.89/sh−12,000→ 1,105,035 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2024-05-29−12,000→ 206,550 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-05-29$22.52/sh−2,123→ 0 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-05-29$21.56/sh−9,877→ 2,123 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-05-29$1.12/sh+12,000→ 12,000 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-04-29$18.48/sh−1,013→ 0 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2024-04-29−12,000→ 218,550 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-04-29$17.86/sh−10,987→ 1,013 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-04-29$1.12/sh+12,000→ 12,000 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-04-11$1.12/sh+30,000→ 30,000 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2024-04-11−30,000→ 230,550 total

Companies

Enliven Therapeutics, Inc.
CHIEF SCIENTIFIC OFFICER
$ELVN

Recent Filings

Address

C/O ENLIVEN THERAPEUTICS, INC. 6200 LOOKOUT ROAD

BOULDER, CO, 80301

View on SEC.gov